Court rules Fresenius can ditch $4.75bn Akorn deal
German drugmaker entitled to end purchase without penalty after whistleblower claims
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Germany Health | Legislation